These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26381852)

  • 1. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
    Rasetti-Escargueil C; Avril A; Chahboun S; Tierney R; Bak N; Miethe S; Mazuet C; Popoff MR; Thullier P; Hust M; Pelat T; Sesardic D
    MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.
    Miethe S; Rasetti-Escargueil C; Liu Y; Chahboun S; Pelat T; Avril A; Frenzel A; Schirrmann T; Thullier P; Sesardic D; Hust M
    MAbs; 2014; 6(2):446-59. PubMed ID: 24492304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B.
    Miethe S; Mazuet C; Liu Y; Tierney R; Rasetti-Escargueil C; Avril A; Frenzel A; Thullier P; Pelat T; Urbain R; Fontayne A; Sesardic D; Hust M; Popoff MR
    PLoS One; 2016; 11(8):e0161446. PubMed ID: 27560688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E.
    Miethe S; Rasetti-Escargueil C; Avril A; Liu Y; Chahboun S; Korkeala H; Mazuet C; Popoff MR; Pelat T; Thullier P; Sesardic D; Hust M
    PLoS One; 2015; 10(10):e0139905. PubMed ID: 26440796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain.
    Avril A; Miethe S; Popoff MR; Mazuet C; Chahboun S; Rasetti-Escargueil C; Sesardic D; Thullier P; Hust M; Pelat T
    BMC Biotechnol; 2015 Sep; 15():86. PubMed ID: 26382731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.
    Derman Y; Selby K; Miethe S; Frenzel A; Liu Y; Rasetti-Escargueil C; Avril A; Pelat T; Urbain R; Fontayne A; Thullier P; Sesardic D; Lindström M; Hust M; Korkeala H
    Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin.
    Chahboun S; Hust M; Liu Y; Pelat T; Miethe S; Helmsing S; Jones RG; Sesardic D; Thullier P
    BMC Biotechnol; 2011 Nov; 11():113. PubMed ID: 22111995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B.
    Matsumura T; Amatsu S; Misaki R; Yutani M; Du A; Kohda T; Fujiyama K; Ikuta K; Fujinaga Y
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32392791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies.
    Rasetti-Escargueil C; Avril A; Miethe S; Mazuet C; Derman Y; Selby K; Thullier P; Pelat T; Urbain R; Fontayne A; Korkeala H; Sesardic D; Hust M; Popoff MR
    Toxins (Basel); 2017 Oct; 9(10):. PubMed ID: 28974033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B.
    Jiang Y; Wang R; Guo J; Cheng K; Chen L; Wang X; Li Y; Du P; Gao C; Lu J; Yu Y; Yang Z
    Front Immunol; 2024; 15():1380694. PubMed ID: 38779676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing toxin-based vaccines against botulism.
    Przedpelski A; Tepp WH; Zuverink M; Johnson EA; Pellet S; Barbieri JT
    Vaccine; 2018 Feb; 36(6):827-832. PubMed ID: 29307477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of a neutralizing antibody against botulinum neurotoxin A.
    Xiong X; Lv S; Fu C; Li L; Sun Z; Han X; Zhang W
    J Immunol Methods; 2020 Dec; 487():112871. PubMed ID: 33007319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries.
    Amersdorfer P; Wong C; Smith T; Chen S; Deshpande S; Sheridan R; Marks JD
    Vaccine; 2002 Feb; 20(11-12):1640-8. PubMed ID: 11858873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E.
    Liu Y; Liu X; Chen W; Yu Y; Meng J; Wang J
    Front Immunol; 2024; 15():1469919. PubMed ID: 39315101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
    Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization mechanism of human monoclonal antibodies against type B botulinum neurotoxin.
    Matsumura T; Kitamura M; Amatsu S; Yamaguchi A; Kobayashi N; Yutani M; Fujinaga Y
    Microbiol Immunol; 2024 Oct; 68(10):348-358. PubMed ID: 39239735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
    Sharma R; Zhao H; Al-Saleem FH; Ubaid AS; Puligedda RD; Segan AT; Lindorfer MA; Bermudez R; Elias M; Adekar SP; Simpson LL; Taylor RP; Dessain SK
    Mol Immunol; 2014 Feb; 57(2):247-54. PubMed ID: 24184879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of a neutralizing antibody specific to internalization domain of Clostridium botulinum neurotoxin type B.
    Yang GH; Kim KS; Kim HW; Jeong ST; Huh GH; Kim JC; Jung HH
    Toxicon; 2004 Jul; 44(1):19-25. PubMed ID: 15225558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
    Pellett S; Bradshaw M; Tepp WH; Pier CL; Whitemarsh RCM; Chen C; Barbieri JT; Johnson EA
    mBio; 2018 Mar; 9(2):. PubMed ID: 29588398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.